Saltar al contenido
Merck

Dietary lipids fuel GPX4-restricted enteritis resembling Crohn's disease.

Nature communications (2020-04-15)
Lisa Mayr, Felix Grabherr, Julian Schwärzler, Isabelle Reitmeier, Felix Sommer, Thomas Gehmacher, Lukas Niederreiter, Gui-Wei He, Barbara Ruder, Kai T R Kunz, Piotr Tymoszuk, Richard Hilbe, David Haschka, Clemens Feistritzer, Romana R Gerner, Barbara Enrich, Nicole Przysiecki, Markus Seifert, Markus A Keller, Georg Oberhuber, Susanne Sprung, Qitao Ran, Robert Koch, Maria Effenberger, Ivan Tancevski, Heinz Zoller, Alexander R Moschen, Günter Weiss, Christoph Becker, Philip Rosenstiel, Arthur Kaser, Herbert Tilg, Timon E Adolph
RESUMEN

The increased incidence of inflammatory bowel disease (IBD) has become a global phenomenon that could be related to adoption of a Western life-style. Westernization of dietary habits is partly characterized by enrichment with the ω-6 polyunsaturated fatty acid (PUFA) arachidonic acid (AA), which entails risk for developing IBD. Glutathione peroxidase 4 (GPX4) protects against lipid peroxidation (LPO) and cell death termed ferroptosis. We report that small intestinal epithelial cells (IECs) in Crohn's disease (CD) exhibit impaired GPX4 activity and signs of LPO. PUFAs and specifically AA trigger a cytokine response of IECs which is restricted by GPX4. While GPX4 does not control AA metabolism, cytokine production is governed by similar mechanisms as ferroptosis. A PUFA-enriched Western diet triggers focal granuloma-like neutrophilic enteritis in mice that lack one allele of Gpx4 in IECs. Our study identifies dietary PUFAs as a trigger of GPX4-restricted mucosal inflammation phenocopying aspects of human CD.

MATERIALES
Referencia del producto
Marca
Descripción del producto

Sigma-Aldrich
(±)-α-Tocoferol, synthetic, ≥96% (HPLC)
Sigma-Aldrich
Glutatión reductasa from baker′s yeast (S. cerevisiae), ammonium sulfate suspension, 100-300 units/mg protein (biuret)
Sigma-Aldrich
Deferoxamine mesylate salt, powder, ≥92.5% (TLC)
Sigma-Aldrich
ββ-Nicotinamida adenina dinucleótico 2′-fosfato reducido tetrasodium salt hydrate, ≥97% (HPLC)
Sigma-Aldrich
cis-4,7,10,13,16,19-Docosahexaenoic acid, ≥98%
Sigma-Aldrich
Cumene hydroperoxide, technical grade, 80%
Sigma-Aldrich
Ferrostatin-1, ≥95% (HPLC)
Sigma-Aldrich
Anti--actina antibody produced in rabbit, affinity isolated antibody, buffered aqueous solution
Sigma-Aldrich
Prostaglandin E2, synthetic, powder, BioReagent, suitable for cell culture
Sigma-Aldrich
L-Glutatión reducido, ≥98.0%
Roche
Kit de detección de muerte celular in situ, POD, sufficient for ≤50 tests
Sigma-Aldrich
Palmitoleic acid, ≥98.5% (GC), liquid
Sigma-Aldrich
Palmitic acid, BioXtra, ≥99%
Sigma-Aldrich
Arachidonic acid, >95.0% (GC)
Sigma-Aldrich
Ácido oleico, ≥99% (GC)
Sigma-Aldrich
Arachidonic acid, from non-animal source, ≥98.5% (GC)
Sigma-Aldrich
Deoxycholic acid, ≥98% (HPLC)
Sigma-Aldrich
Ursodeoxycholic acid, ≥99%
Sigma-Aldrich
Lipopolysaccharides from Escherichia coli O55:B5, purified by ion-exchange chromatography, TLR ligand tested
Sigma-Aldrich
cis-5,8,11,14,17-Eicosapentaenoic acid, ≥99%
Amersham Hybond® P Western blotting membranes, PVDF, pore size 0.45 μm, roll W × L 300 mm × 4 m, pkg of 1 ea
Sigma-Aldrich
Colagenasa from Clostridium histolyticum, 0.2 μm filtered, suitable for release of physiologically active rat hepatocytes, Type IV-S, 0.5-5.0 FALGPA units/mg solid, ≥125 CDU/mg solid
Sigma-Aldrich
2-(Diisopropylamino)ethyl methacrylate, 97%, contains ~100 ppm monomethyl ether hydroquinone as inhibitor
Sigma-Aldrich
all-cis-7,10,13,16,19-Docosapentaenoic acid, synthetic, ≥97%
Sigma-Aldrich
β-Thujaplicin, 99%
Sigma-Aldrich
Bay 11-7082, ≥98% (HPLC), powder
Sigma-Aldrich
Iron(III) sulfate hydrate, BioReagent, suitable for plant cell culture
Sigma-Aldrich
Colato de sodio hydrate, suitable for cell culture, BioReagent
Sigma-Aldrich
Deoxyribonuclease II from bovine spleen, Type V, essentially salt-free, lyophilized powder, ≥1,000 units/mg protein
Sigma-Aldrich
Stearidonic acid, ≥99%